Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
Clinical trial NCT02580591 · COMPLETED
Trial details
- NCT number
- NCT02580591
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2017-09-12
- Enrollment
- 977
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.